Carl P. Decicco
Chief Scientific Officer
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Foghorn Therapeutics Inc. (FHTX)
Proxy statement
Start not stated–2022-01-31
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Foghorn Therapeutics Inc. (FHTX) | Former Chief Scientific Officer | $428,500 | $1,809,604 |
| 2020 | Foghorn Therapeutics Inc. (FHTX) | Former Chief Scientific Officer | $412,000 | $1,218,464 |
| 2019 | Foghorn Therapeutics Inc. (FHTX) | Chief Scientific Officer | $400,000 | $2,070,337 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.